Synthalis Limited


AI-native medtech company developing medical devices and AI-driven biopharma capabilities. Product development focus includes portable oxygen systems, wearable/implantable devices for ocular and respiratory applications, and an in‑silico drug discovery pipeline. Operates from the UK and cites partnerships and a patent-driven product strategy.

Industries

N/A

Synthalis Limited


Products

Ocuhalo

A corneal graft halo retainer ring intended to encircle and stabilise corneal grafts during healing; designed to be secured with sutures and removed after healing. Constructed from lightweight biocompatible titanium.

Oxylert

A wearable system combining a glasses-mounted interface and a portable oxygen concentrator. Uses inertial sensors and nasal pulse oximetry to detect drowsiness and supply ionised oxygen locally to the nose and mouth.

Oxyvia

A compact oxygen delivery system intended for public emergency cabinets, first-aid stations, ambulances, field hospitals and remote/military kits; integrates a PEM electrochemical oxygen generation approach to supply oxygen without traditional compressors.

Somnoxia

A sleep mask system combining a filtration and control unit with a removable silicone face seal and ergonomic straps; designed to monitor sleep-related motion and modulate inspired oxygen to alter blood oxygen saturation with an integrated failsafe.

Expertise Areas

  • Medical device development
  • Portable oxygen and respiratory systems
  • Wearable sensor integration and embedded systems
  • AI-driven in-silico drug discovery
  • Show More (3)

Key Technologies

  • Proton-exchange membrane (PEM) electrochemical oxygen generation
  • Pulse oximetry (nasal/continuous)
  • Inertial sensors (3-axis gyroscope and accelerometer)
  • Biocompatible titanium implant fabrication
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.